Loading clinical trials...
Loading clinical trials...
This randomized clinical trial studies a group-based lifestyle intervention or usual care in measuring biomarker levels in participants at high risk for breast cancer. Studying the effects that change...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
University of Washington
Collaborators
NCT01905046 · Atypical Ductal Breast Hyperplasia, BRCA1 Mutation Carrier, and more
NCT01975363 · Atypical Ductal Breast Hyperplasia, BRCA1 Gene Mutation, and more
NCT00899145 · BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, and more
NCT01154426 · Adult Solid Neoplasm, BRCA1 Mutation Carrier, and more
NCT00897455 · brca1 Mutation Carrier, brca2 Mutation Carrier, and more
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Seattle, Washington
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions